Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172219 · ClinicalTrials.gov registry record · NA
Evaluation of Electronic Portal Messaging and Embedded Asynchronous Care on Physician-Assisted Smoking Quit Attempts
A NA study, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT05172219: Completed NA study, sponsored by Oklahoma State University Center for Health Sciences.
NCT05172219 is a NA study that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05172219, a NA study, has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Among 10 PCPs, 200 adult smokers with an active patient portal who had been seen by a PCP within 12 months were randomly selected and randomly assigned to one of four conditions to compare the quit attempts of patients sent electronic outreach with and without asynchronous care link and to compare the quit attempts of patients who recieved the portal message from PCP or the health system.
Primary Outcome
Smoking Quit Attempt documented in the EMR
Interventions
- BEHAVIORAL Physician Sent Outreach with Embedded Asynchronous Care in Portal Message
- BEHAVIORAL Physician Sent Outreach without Embedded Asynchronous Care in Portal Message
- BEHAVIORAL System Sent Outreach with Embedded Asynchronous Care in Portal Message
- BEHAVIORAL System Sent Outreach without Embedded Asynchronous Care in Portal Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-01-13 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT05172219 record still lists
NCT05172219 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 4 interventions - of which Physician Sent Outreach with Embedded Asynchronous Care in Portal Message is the first listed.
NCT05172219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05172219 about?
NCT05172219 is a clinical study titled "Evaluation of Electronic Portal Messaging and Embedded Asynchronous Care on Physician-Assisted Smoking Quit Attempts". Among 10 PCPs, 200 adult smokers with an active patient portal who had been seen by a PCP within 12 months were randomly selected and randomly assigned to one of four conditions to compare the quit attempts of patients sent electronic outreach with and without asynchronous care link and to compare t...
What is the current status of trial NCT05172219?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2020-01-13. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT05172219?
The interventions under investigation include: Physician Sent Outreach with Embedded Asynchronous Care in Portal Message (BEHAVIORAL), Physician Sent Outreach without Embedded Asynchronous Care in Portal Message (BEHAVIORAL), System Sent Outreach with Embedded Asynchronous Care in Portal Message (BEHAVIORAL), System Sent Outreach without Embedded Asynchronous Care in Portal Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT05172219?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05172219's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI